Clinical trial
Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
NCT00488163 · Research Foundation for Mental Hygiene, Inc., Other · Completed
Key facts
| NCT number | NCT00488163 |
|---|---|
| Title | Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia |
| Official title | Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia |
| Lead sponsor | Research Foundation for Mental Hygiene, Inc., Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Atomoxetine |
| Enrollment | 20 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jun 20, 2007 |
| Last update posted | Oct 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: